Search Results
Viewing: 41-50 of 303 | All
News
New Initiative Aims to Improve Diagnosis and Treatment of Children with Solid Tumors Through Molecular Analysis
The National Cancer Institute (NCI), part of the National Institutes of Health, Children’s Oncology Group (COG), and Nationwide Children's Hospital are poised to change the direction of pediatric cancer diagnosis and care. New results from international efforts to characterize pediatric cancers have led to the Molecular Characterization Initiative: a project that aims to collect, analyze, and report clinical molecular data to support COG-affiliated clinicians in choosing the best treatment for each child. This program is part of the NCI Childhood Cancer Data Initiative (CCDI).
Specialty
Hydrocephalus Program
At Nationwide Children’s Hospital, the Hydrocephalus Program cares for children with hydrocephalus at every stage — from before birth through young adulthood. Led by Albert M. Isaacs, MD, PhD, a nationally recognized leader in pediatric hydrocephalus care and research, our team brings together experts from multiple specialties to deliver coordinated, personalized treatment.
Article
Dennis R. Durbin
Dennis R. Durbin, MD, MSCE, is president of the Abigail Wexner Research Institute (AWRI) at Nationwide Children’s Hospital, a professor of Pediatrics at The Ohio State University College of Medicine and vice chair for Research in the Department of Pediatrics.
2025 Ohio EMS for Children Conference
Join us for the 2025 Annual Ohio EMS for Children Conference, focusing on the unique emergency care needs of children.
News
Nationwide Children's Hospital Ranked Among Top Hospitals in Ohio on Forbes List of “America’s Best Employers”
Nationwide Children’s Hospital has been named one of “America’s Best Employers” by Forbes for the fifth consecutive year.
News
Right Care, Right Place, Right Time? Frequency and Duration of Boarding for Pediatric Mental Health Conditions at Acute Care Hospitals
According to the results of a national survey conducted, in part by a researcher at Nationwide Children’s Hospital, mental health boarding in emergency departments (ED) and/or hospital inpatient settings is common with a median of 4 patients daily and associated with median durations of 48 hours – 10 times longer than standards established by the Joint Commission. In addition, in these acute care settings, youths received minimal mental health services during their lengthy boarding. Unfortunately, these patients are getting the wrong care, in the wrong place and at the wrong time. The study was published in the Journal of the American Medical Association.
News
FDA Approves First Gene Therapy Treatment for Duchenne Muscular Dystrophy Developed at the Abigail Wexner Research Institute at Nationwide Children’s Hospital
Today, the Abigail Wexner Research Institute at Nationwide Children’s Hospital praised the Food and Drug Administration (FDA) for its accelerated approval of SRP-9001/ELEVIDYS for Duchenne muscular dystrophy (DMD) following decades of research in its Center for Gene Therapy to help patients with neuromuscular diseases.
News
Researchers Identify Potential Prenatal Biomarkers of Congenital Heart Diseases
In a research letter recently published in Circulation Research, researchers at Nationwide Children’s describe a potential biomarker that would identify the presence of SVHD in a fetus based on a maternal blood test.
News
Cynthia Gerhardt, PhD, Named Chief Clinical Research Officer at Nationwide Children's Hospital
Cynthia A. Gerhardt, PhD, director, Center for Biobehavioral Health in the Abigail Wexner Research Institute at Nationwide Children's Hospital, has been appointed Chief Clinical Research Officer (CCRO) at Nationwide Children's.
Specialty
Heart Transplant Program
Heart transplants save and change lives. The heart transplant team at Nationwide Children’s focuses on maximizing a patient’s health before, during and after transplantation. Our goal is to help our patients achieve an ideal outcome after their heart transplant.